search icon
  • Print
  • ShareThis
  • Text Size
  • IDSA members can sign up for these services online. (To subscribe, check the appropriate boxes to receive CDC’s  messages and/or alerts from FDA, and provide your email address and name where indicated.)

     

     

    Resources on Serogroup B Meningococcal Vaccine and Princeton meningococcal disease outbreak 

     

    Princeton University has been experiencing an outbreak of meningococcal disease since spring 2013.  All seven of the cases were caused by meningococcal bacteria known as serogroup B ("strain" B). Working with CDC and the New Jersey Department of Health, the University has decided to make arrangements to provide their students access to a serogroup B meningococcal vaccine as soon as possible.  FDA will allow the use of the vaccine at Princeton University under an Investigational New Drug application.  The outbreak and plans for a vaccination effort have received media attention and we understand partners may have and/or be receiving questions.  Please be aware that you can get information from the University, the New Jersey Department of Health (PDF) and CDC.  We will continue to update and add to the questions and answers on the CDC webpage as needed.

 

Average 0 out of 5

| HIVMA | Contact Us

© Copyright IDSA 2013 Infectious Diseases Society of America

Full Site Mobile Site